Skip to main content
. 2015 Mar 26;6(14):12110–12127. doi: 10.18632/oncotarget.3661

Figure 5. Comparison of tissue and serum samples.

Figure 5

Bar diagram showing averaged relative expression values from available serum (blue), normal skin (red), primary tumour lesion (green) and metastatic lesions (purple) samples. Arrows indicate gradually increasing expression of miRNA with progression of disease, stars highlight miRNAs that were only detected in tissue samples but not in serum, dots mark miRNAs with serum expression only. Expression levels of single samples can be seen in Supplementary Fig. S3.